Rocket Lab Corporation RKLB is building a credible multi-year growth setup, helped by durable government demand and a staged backlog that supports near-term visibility. The tradeoff is

Rocket Lab Corporation RKLB enters 2026 with a clearer revenue foundation than it had in prior years. The company is pairing a large contracted backlog with a higher operating tempo in Electron and

Rocket Lab Corporation RKLB is seeing defense urgency translate into durable demand signals across launch and space systems. That demand is showing up in hypersonic activity, expanding program

DENTSPLY SIRONA XRAY is well positioned for growth due to its new digital-implant workflow and continued focus on research and development. However, forex headwinds and demand softness in Europe

Abbott Laboratories’ ABT strong sales recovery within the Nutrition business, driven by the robust sales performance of Ensure, is poised to drive growth in the upcoming quarters. Within Diabetes

Applied Materials AMAT shares have climbed 33% year to date, outperforming the Zacks Electronics - Semiconductors industry and the Zacks Computer and Technology sector’s decline 5.5% and 11.5%

Cardinal Health’s CAH evolving “specialty flywheel” strategy is emerging as a powerful engine for long-term growth, driven by the integration of distribution, MSO platforms and biopharma services

PVH Corporation PVH posted fourth-quarter fiscal 2025 results, wherein both revenues and earnings topped the Zacks Consensus Estimate. Both metrics also increased year over year. PVH ended 2025 on a

Tempus AI’s TEM Diagnostics arm is transitioning from a traditional testing business into a highly differentiated, AI-powered clinical intelligence platform. The business delivered a strong and